Grant: Project Grant
Université Laval
$680,850.00
Understanding Head and Neck Squamous Cell Carcinoma onset in young adults
EF 2017-18
Résumé
Cancer of the head and neck region is the sixth leading cancer in the world. It is a very aggressive cancer with poor survival. Treatments are very aggressive with severe side effects, which leave patients with poor quality of life. Our research is aimed at understanding
why patients with the genetic disease Fanconi Anemia suffer from cancers of the head and neck more frequently and at a younger age than the general population. Through this proposed research, we plan to identify defects in cells that promote head and neck cancers with the hope of developing better treatments.
Programme
Project Grant
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
379981
Name
Carreau Madeleine
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Cancer Progression & Therapeutics
Projecttitle
Understanding Head and Neck Squamous Cell Carcinoma onset in young adults
Programtype2
Operating Grants
Orgnameinp2
Université Laval
Cihramount2
$680,850
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Dickkopf1; Fanconi Anemia; Head And Neck Cancers; Prognostic Tool; Young Adults
Abstract
Cancer of the head and neck region is the sixth leading cancer in the world. It is a very aggressive cancer with poor survival. Treatments are very aggressive with severe side effects, which leave patients with poor quality of life. Our research is aimed at understanding
why patients with the genetic disease Fanconi Anemia suffer from cancers of the head and neck more frequently and at a younger age than the general population. Through this proposed research, we plan to identify defects in cells that promote head and neck cancers with the hope of developing better treatments.
Competitiondate
201803
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Carreau, Madeleine
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $680,850~ $0~
